Effect of streptozotocin diabetes on motor and inhibitory transmission in rat anococcygeus
- PMID: 1337014
- DOI: 10.1139/y92-192
Effect of streptozotocin diabetes on motor and inhibitory transmission in rat anococcygeus
Abstract
The effect of streptozotocin diabetes of 4-week duration on the adrenergic motor transmission and on the nonadrenergic, noncholinergic, inhibitory transmission in the rat anococcygeus was investigated by recording contractile and relaxant activity of isolated muscle preparations taken from diabetic and age-matched control animals. The neurogenic contractile responses to electrical field stimulation were significantly reduced in the preparations from diabetic rats. The inhibitory transmission remained unaffected in the diabetic rats. Concentration--response curves showed no change in sensitivity of the diabetic anococcygei to noradrenaline. The maximum tension generated was also similar in preparations from diabetic and nondiabetic animals. The contractile responses to electrical field stimulation were significantly greater in preparations from diabetic rats treated for 4 weeks with either sorbinil (20 mg.kg-1.day-1 orally) or myo-inositol (667 mg.kg-1.day-1 orally) when compared with the untreated diabetic controls; the sensitivity to noradrenaline was identical in all three groups. It is concluded that streptozotocin diabetes causes a significant reduction of adrenergic contractile responses of the anococcygeus to electrical field stimulation by a prejunctional mechanism, and the reduction can be prevented by treating the animals with the aldose reductase inhibitor sorbinil or with myo-inositol.
Similar articles
-
Nitric oxide-mediated neurotransmission is attenuated in the anococcygeus muscle from diabetic rats.Diabetologia. 1994 Mar;37(3):232-7. doi: 10.1007/BF00398048. Diabetologia. 1994. PMID: 8174835
-
Inhibitory effect of streptozotocin-induced diabetes on non-cholinergic motor transmission in rat detrusor and its prevention by sorbinil.Br J Pharmacol. 1990 Oct;101(2):411-7. doi: 10.1111/j.1476-5381.1990.tb12723.x. Br J Pharmacol. 1990. PMID: 2175235 Free PMC article.
-
The aldose reductase inhibitor sorbinil does not prevent the impairment in nitric oxide-mediated neurotransmission in anococcygeus muscle from diabetic rats.Eur J Pharmacol. 1996 Dec 27;318(1):101-8. doi: 10.1016/s0014-2999(96)00751-0. Eur J Pharmacol. 1996. PMID: 9007520
-
Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.Diabetes. 1984 May;33(5):470-6. doi: 10.2337/diab.33.5.470. Diabetes. 1984. PMID: 6202576
-
Aldose reductase inhibitors and late complications of diabetes.Drugs. 1986;32 Suppl 2:43-55. doi: 10.2165/00003495-198600322-00010. Drugs. 1986. PMID: 3098544 Review.
Cited by
-
Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats.Dig Dis Sci. 1997 Oct;42(10):2106-10. doi: 10.1023/a:1018830820537. Dig Dis Sci. 1997. PMID: 9365143
-
Nitric oxide-mediated neurotransmission is attenuated in the anococcygeus muscle from diabetic rats.Diabetologia. 1994 Mar;37(3):232-7. doi: 10.1007/BF00398048. Diabetologia. 1994. PMID: 8174835
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical